N-ECCO survey results of nursing practice in caring for patients with Crohn's disease or ulcerative colitis in Europe
PDF) P756 Assessment of metal exposures in deciduous teeth of patients with inflammatory bowel disease
10th Congress of ECCO
PDF) P743 What information is available on the internet and social media for faecal microbiota transplantation?
East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
European Crohn's and Colitis Organisation Topical Review on Complementary Medicine and Psychotherapy in Inflammatory Bowel Dis
ECCO » ECCO Meetings
Home
Kevin Whelan on Twitter: "Interested to learn more about #IBD? Prof James Lindsay promotes use of the ECCO-e learning platform https://t.co/f6faP7NIRI #IBDdiet #ECCO… https://t.co/veMvbyI8WR"
PDF) P698 Persistence, clinical effectiveness and safety of vedolizumab in the post-marketing real clinical practice in Italy: a double-centre, 2-year experience in Crohn's disease and ulcerative colitis patients
PDF) P728 Changes in the use of biologics in the treatment of IBD patients over time. Results from a comprehensive Norwegian registry study
PDF) P775 Evolution of inflammatory bowel disease research from a bird's eye perspective: A text-mining analysis of publication trends and topics
Introduction
N029 Patients experience of advice received on the use of topical therapies in inflammatory bowel disease (IBD) N030 Real benefi
PDF) P374 Non-alcoholic fatty liver disease in inflammatory bowel disease: Prevalence and risk factors
PDF) ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
nowości pediatryczne na 9. Kongresie eCCO 2014 w Kopenhadze
Past Congresses
PDF) P045 The relationship between thiol/disulphide and inflammatory bowel disease
PDF) ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment
Untitled
ECCO | OH Cards NA
Figure 1 | Economic Impact of Non-Medical Switching from Originator Biologics to Biosimilars: A Systematic Literature Review | SpringerLink
Home
